Melanotan II protocol
Melanotan II (cyclic alpha-MSH analog). The published work on this compound is animal or cell-culture research. No human dosing schedule exists to cite.
How Melanotan II works
A cyclic, non-selective melanocortin agonist. Unlike Melanotan I it hits MC1, MC3, MC4 and MC5 — the MC4 activity is why it produces sexual and appetite effects alongside pigmentation, and PT-141 is a metabolite of it.
Melanotan II dosing — what the literature actually supports
We publish a schedule when there is a citable human source and we say so when there is not. Filling this space with a number nobody measured would make the page look more complete and be worth less than nothing to you.
Reconstitution and measurement
This part is arithmetic and does not depend on the evidence level. Concentration is vial size divided by the bacteriostatic water you add. Draw volume is your target amount divided by that concentration. Units are draw volume times 100, because a U-100 syringe reads 100 units per millilitre. Common vials for Melanotan II: 10 mg.
Storage and stability
Reported effects
- No approved label or established schedule.
- Nausea and flushing are widely reported; darkening and change in appearance of moles is a documented and specific concern with non-selective melanocortin agonists.
- Case reports link unregulated Melanotan II use to melanoma diagnoses and to rhabdomyolysis; causality is not established but the reports exist and regulators have cited them.
Sourcing Melanotan II
Whatever you are working with, the documentation matters more than the price. Ask for a batch certificate of analysis whose lot number matches the vial you actually receive — a COA for a different batch tells you nothing about yours.
Melanotan II at Summit Research Supply → Grade a COA first
Summit is the supplier we feature and an affiliate link. Our COA checklist applies the same way to any vendor.
